The converging axis involving sphingomyelinase and sphingosine-1-phosphate, mediated by the actions of sphingomyelinase SMPD1 and sphingosine-kinase SPHK1, emerged as a pivotal factor in glioma. This evidence concerns the gene SPHK1 and central nervous system cancer.